FDAClass IIIFebruary 15, 2023

Atropine Sulfate Ophthalmic Solution recall

Atropine Sulfate Ophthalmic Solution, USP 1%, For Topical Application To The Eye, 2 mL bottle, Sterile, Rx only, Distributed by: Akorn Operating Company LLC, Gurnee, IL 60031. NDC: 17478-215-02

Why was Atropine Sulfate Ophthalmic Solution recalled?

Failed Stability Specifications: Out of specification test results for viscosity was identified at the 12M stability timepoint.

What should I do if I have this product?

The recall is ongoing. Follow the firm and FDA instructions.

What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.

Is my product affected?

Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.

Which lot codes, UPCs or models are affected?

Lot: 081031A, Exp 2/28/2023

Product
Atropine Sulfate Ophthalmic Solution, USP 1%, For Topical Application To The Eye, 2 mL bottle, Sterile, Rx only, Distributed by: Akorn Operating Company LLC, Gurnee, IL 60031. NDC: 17478-215-02
Recalling firm
Akorn, Inc.
Quantity
45,117 Bottles
Distribution
Nationwide in the USA and Puerto Rico
Recall date
February 15, 2023
Classification
Class III
Status
Ongoing
Agency
FDA (drug)
Open FDA enforcement record Latest recalls